Neurogene
Logotype for Neurogene Inc

Neurogene (NGNE) investor relations material

Neurogene Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Neurogene Inc
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary12 Feb, 2026

Company overview and lead program

  • Focuses on genetic medicines for rare neurologic diseases using a biology-first approach.

  • Lead program NGN-401 targets Rett syndrome, a multi-billion dollar market with 15,000–20,000 patients in the US and Europe.

  • NGN-401 pivotal study began dosing in Q4 2025, with enrollment and dosing completion expected in Q2 2026.

  • Phase I/II data showed 35 milestones gained across 8 participants, indicating multi-domain, durable improvements.

  • Upcoming catalyst is the completion of enrollment and 12-month data readout for all 10 patients in mid-2026.

Differentiation and technology

  • NGN-401 uses a full-length human MECP2 gene and proprietary technology to regulate expression, minimizing toxicity.

  • Delivery method ensures drug reaches neurons in the brain, addressing the root cause of Rett syndrome.

  • Route of administration (ICV) is supported by caregivers, KOLs, and payers, who prioritize efficacy over delivery concerns.

  • Payers focus on clear, objective efficacy endpoints, such as milestone gains.

Safety, dosing, and monitoring

  • Previous HLH event at higher dose (3E15); current pivotal dose (1E15) is three times lower and has shown no HLH cases.

  • Monitoring protocol includes ferritin and other immune markers for early detection and reversibility of adverse events.

  • Nerve conduction issues observed were transient and align with known AAV gene therapy class effects.

  • Safety updates will be disclosed if material events occur; current data shows no new safety concerns.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Neurogene earnings date

Logotype for Neurogene Inc
TD Cowen 46th Annual Health Care Conference4 Mar, 2026
Neurogene
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Neurogene earnings date

Logotype for Neurogene Inc
TD Cowen 46th Annual Health Care Conference4 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Neurogene Inc. (NGNE) is a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases. Utilizing its proprietary transgene regulation technology, known as Expression Attenuation via Construct Tuning (EXACT), Neurogene aims to address high unmet medical needs that are not effectively treated by conventional gene therapies. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage